Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2011-08-16
2011-08-16
Stucker, Jeffrey (Department: 1647)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S377000, C514S001100, C514S007900, C514S451000
Reexamination Certificate
active
07998740
ABSTRACT:
Methods and compositions for treating cells with cytokines are provided herein.
REFERENCES:
patent: 6887704 (2005-05-01), Peled et al.
patent: 2003/0040607 (2003-02-01), Sackstein
patent: 2004/0076619 (2004-04-01), Anversa et al.
patent: 2006/0210558 (2006-09-01), Sackstein
patent: 2008/0044383 (2008-02-01), Sackstein
patent: 2009/0239296 (2009-09-01), Sackstein
Katayama et al., J Exp Med. Apr. 18, 2005; 201(8): 1183-1189.
Katoh et al., The Journal of Immunology, 1999, 162: 5058-5061.
Hakansson, L. et al. Br. J. Haematol. 98, 603-611 (1997).
(Cameron, “Cytokines, Chemokines and Their Receptors”—Madame Curie Bioscience Database; access from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=eurekah&part=A13503 on Mar. 4, 2010.
McKinstry et al., (Blood. Jan. 1, 1997;89(1):65-71).
Adler et al., “Fatal sickle cell crisis after granulocyte colony-stimulating factor administration”, Blood, 97: 3313-33149 (2001).
Albert, R. K., “Mechanisms of the adult respiratory distress syndrome: selectins”, Thorax, 50 (Suppl 1):S49-52 (1995).
Arimura et al., “Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone”, Haematologica 90, ECR10 (2005).
Azoulay et al., “Exacerbation by granulocyte colony-stimulating factor of prior acute lung injury: implication of neutrophils”, Crit. Care Med., 30:2115-22 (2002).
Azoulay et al., “Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic Review of Clinical Case Report Experimental Data”, Chest, 120:1695-701 (2001).
Bussolino et al., “Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate”, Nature, 337:471-3 (1989).
Butcher, E. C., “Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity”, Cell, 67:1033-6 (1991).
Cowland et al., “Isolation of neutrophil precursors from bone marrow for biochemical and transcriptional analysis”, J. Immunol. Meth., 232:191-200 (1999).
Dereure et al., “Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome”, Brit. J. Dermatol., 150:1228-30 (2004).
Dimitroff et al., “CD44 is a major E-selectin ligand on human hematopoietic progenitor cells”, J. Cell. Biol., 153:1277-86 (2001).
Dimitroff et al., “A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells”, Proc. Natl. Acad. Sci. USA, 97:13841-6 (2000).
Dimitroff et al., “Differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, Hcell and PSGL-1”, J. Biol. Chem., 276:47623-31 (2001).
Elfenbein et al., “Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow”, Exp. Hematol., 32:327-39 (2004).
Ellies et al., “Sialyltransferase specificity in selectin ligand formation”, Blood, 100:3618-25 (2002).
Faulkner et al., “G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective”, Bone Marr. Tran., 21:1091-5 (1998).
Fuhlbrigge et al., “Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells”, Nature, 389:978-81 (1997).
Fuhlbrigge et al., “Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots”, J. Immunol., 168:5645-51 (2002).
Fukumoto et al., “Angina pectoris occurring during granulocyte colony-stimulating factor- combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia”, Brit. J. Haematol., 97:666-8 (1997).
Fuste et al., “Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK”, Haematologica., 89:578-85 (2004).
Glass et al., “A generalized cutaneous reaction induced by granulocyte colony-stimulating factor”, J. Am. Acad. Dermatol., 34:455-9 (1996).
Goetz et al., “Isolated P-selectin glycoprotein ligand-1 dynamic adhesion to P- and E-selectin”, J. Cell. Biol., 137:509-19 (1997).
Groves et al., “Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation”, Brit. J. Dermatol., 124:117-23 (1991).
Hakansson et al., “Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion”, Brit. J. Haematol., 98:603-11 (1997).
Harada et al., “G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes”, Nat. Med., 11:305-11 (2005).
Hill et al., “The end of granulocyte colony-stimulating factor in acute myocardial infarction? Reaping the benefits beyond cytokine mobilization”, Circulation, 113:1926-8 (2006).
Hill et al., “Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease”, J. Am. Coll. Cardiol., 46:1643-8 (2005).
Jain, K. K., “Cutaneous vasculitis associated with granulocyte colony-stimulating factor”, J. Am. Acad. Dermatol., 31:213-5 (1994).
Jilma et al., “Rapid down modulation of P-selectin glycoprotein ligand-1 (PSGL-1, CD162) by G-CSF in humans”, Transfusion, 42:328-33 (2002).
Kansas, G. S., “Selectins and their ligands: current concepts and controversies”, Blood, 88:3259-87 (1996).
Kieffer et al., “Neutrophils, monocytes, and dendritic cells express the same specialized form of PSGL-1 as do skin-homing memory T cells: cutaneous lymphocyte antigen”, Biochem. Biophys. Res. Commun., 285:577-87 (2001).
Kriegsmann et al., “Expression of E-selectin messenger RNA and protein in rheumatoid arthritis”, Arth. Rheum., 38:750-4 (1995).
Kunkel et al., “Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo”, Circ. Res., 79:1196-204 (1996).
Laszik et al., “P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some non-hematopoietic cells”, Blood, 88:3010-21 (1996).
Lindemann et al. “Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF)”, Eur. J. Can., 29A:2338-9 (1993).
Mossner et al., “Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation”, Exp. Dermatol., 13:340-6 (2004).
Ohsaka et al., “Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo”, Brit. J. Haematol., 84:574-80 (1993).
Sackstein, R., “The lymphocyte homing receptors: gatekeepers of the multistep paradigm”, Curr. Opin. Hematol.,12:444-50 (2005).
Schleiffenbaum et al., “Soluble L-selectin is present in human plasma at high levels and retains functional activity”, J. Cell. Biol., 119:229-38 (1992).
Sipkins et al., “In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment”, Nature, 435:969-73 (2005).
Smith et al., “CXCR2- and E-selectin-induced neutrophil arrest during inflammation in vivo”, J. Exp. Med., 200:935-9 (2004).
Spertini et al., “P-selectin glycoprotein ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34+ hematopoietic progenitor cells”, J. Cell. Biol., 135:523-31 (1996).
Stricker et al., “G-CSF and exacerbation of rheumatoid arthritis”, Am.
Gamett Daniel C
Kozakiewicz, J.D. Cynthia A.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Stucker Jeffrey
LandOfFree
Cytokine induction of selectin ligands on cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytokine induction of selectin ligands on cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytokine induction of selectin ligands on cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2735102